Apligraf® - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a ...
More than three million United States adults suffer from venous ulcers, suggested a new report from THE SAGE GROUP. The cost of venous disease represents a significant burden on patients and the U.S.
Organogenesis, Inc. announced that its Apligraf® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug ...
Biotherapeutic Cell-based Product from Organogenesis Meets Switzerland's Highest Clinical and Safety Standards CANTON, Massachusettsand REINACH, Switzerland, Nov. 2, 2015 /PRNewswire/ --Organogenesis ...
Apligraf® - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a ...
Ron Frazier of Annandale is a surprisingly happy man. Consider that, at age 69, he has diabetes, congestive heart failure and an open foot wound. In addition, the toes on his left foot have been ...
One of the first things visitors to the Organogenesis production areas see are two numbers – 10,000 and 100. The Canton biotech firm’s skin-regeneration business starts with those numbers, which show ...
Organogenesis Inc., a Canton-based company that makes tissue replacements using living cells, has entered into discussions with Novartis Pharma AG to reacquire commercialization rights to its Apligraf ...
Biotherapeutic Cell-based Product from Organogenesis Meets Switzerland's Highest Clinical and Safety Standards Apligraf is a biotherapeutic wound-healing technology that contains two layers of human ...
Diabetic Foot Ulcers a Widespread and Growing Problem in Gulf States The Kingdom of Saudi Arabia, with a population of more than 29 million, is the largest and most affluent of the Gulf Co-operation ...
Organogenesis, Inc. announced that its Apligraf bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results